Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

RNA POLYMERASE FOR SYNTHESIS OF MODIFIED RNA

LIGAND DETECTION BY APTAMERS WITH A BUILT-IN REPORTER

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

APTAMER AGAINST IRINOTECAN

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

RNA nanoparticles and method of use thereof

Nucleic acid nanocarrier drug, preparation method, pharmaceutical composition and use thereof

Method for synthesizing single-stranded dna

COMPOSITIONS AND METHODS OF USE FOR SMALL-MOLECULE REGULATION OF CRISPR-CAS9 ACTIVITY USING RNA APTAMERS

APTAMERS AND THE USE THEREOF IN THE TREATMENT OF CANCER

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Short DNA aptamers and methods for promoting remyelination

Root exudate-activated system for agrochemical delivery

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID ANTICOAGULANTS

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Analytes' detection using regulated in vitro transcription

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

BIOSENSOR AND METHOD FOR DETECTION OF ANALYTES

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Use of aptamers in proteomics

Composition comprising aptamer as active ingredient for treatment and prevention of degenerative brain disease

METHOD FOR PREVENTING OXIDATION OF POLYPHENOL BY MEANS OF APTAMER, MATERIAL THEREOF, AND USE THEREOF

COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

PROGNOSIS AND TREATMENT OF METASTATIC CANCER

CXCL8 Binding Nucleic Acids

Peptides, combination of peptides as targets and for use in immunotherapy

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

Aptamer-based sensors for detection of fentanyl opioids

SELF-ASSEMBLING NUCLEIC ACID SURFACES FOR BIOSENSOR APPLICATIONS

COMPOSITIONS AND METHODS FOR THE SYNTHESIS AND IDENTIFICATION OF COVALENT APTAMERS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

MODIFIED NUCLEIC ACID HAVING IMPROVED TREATMENT EFFICACY, AND ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING SAME

Oligomers

APTAMERS AND USES THEREOF

Hybridization chain reaction methods for in situ molecular detection

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS

Astrocyte-specific nucleic acid aptamer and use thereof

High efficiency aptamer complex comprising branched DNA and aptamer, and use thereof

Methods for treating or preventing ophthalmological conditions

BIOLOGICS ENGINEERING VIA APTAMOMIMETIC DISCOVERY

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

COMPOSITIONS AND METHODS INVOLVING APTAMER SWITCH POLYNUCLEOTIDES

Peptides and combination of peptides for use in immunotherapy against various cancers

Functional ligands to opioids and opioid derivatives

Molecular fuses for real-time, label-free, multiplexed imaging of RNAs in living cells

Peptides and combination of peptides for use in immunotherapy against various cancers

RNA molecules, methods of producing circular RNA, and treatment methods

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides for use in immunotherapy against cancers

Peptides for use in immunotherapy against cancers

ENCAPSULATION AND HIGH ENCAPSULATION EFFICIENCY OF PHOSPHORYLATED ACTIVE AGENTS IN NANOPARTICLES

BLOOD-BRAIN BARRIER PERMEABLE APTAMER AND APPLICATION THEREOF

Aptamers Against Clostridium Difficile

Aptamer therapeutics useful in the treatment of complement-related disorders

Compositions and methods involving non-natural aptamer libraries

Compositions containing nucleic acid nanoparticles with modular functionality

CCR7 aptamers and uses thereof

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination thereof for use in the immunotherapy against cancers

Nucleic Acid Compounds for Binding Immunoglobulin G

INHIBITOR OF TDP-43 AGGREGATION

USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19

METHOD OF IDENTIFYING OR PRODUCING AN APTAMER FOR A DENATURED PEPTIDE OR PROTEIN

Exogenous control of mammalian gene expression through aptamer-mediated modulation of polyadenylation

Uterine cancer treatments

SYSTEMS AND METHODS FOR APTAMER-BASED INTRACELLULAR DELIVERY OF A PAYLOAD USING NANONEEDLES

Multiple rapid detection kits and methods for various viruses

DNA aptamers, method for inhibiting human galectin-1 and method of treating a mammal in need thereof

Uterine cancer treatments

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR

ICAM-1 aptamers, diagnostic and therapeutic uses thereof

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

Aptamer-based CAR T-cell switch

Method for producing dextran polymer-based, amplified nucleic acid aptamer nanoconstruct selectively capturing target molecule

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Methods of Imaging and Tracking Nucleic Acids in Cells

ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS WITH NEW ARCHITECTURES FOR SEQUENCE MANIPULATION

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

APTAMER PREPARATION

COMPOSITIONS AND METHODS RELATED TO APTAMER-BASED REVERSIBLE CELL SELECTION

Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers

Methods for the treatment of tissue lesions with CCR2 agonists

Anti-IL1RAP antibodies and their use for treating humans

Matrix bound nanovesicles and their use

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

METHODS FOR CAPTURE AND ANALYSIS OF MACROMOLECULAR COMPLEXES

TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases

ANTIGEN-BINDING FRAGMENT AND/OR APTAMER FOR BINDING TO AN EXTRACELLULAR PART OF CD9 AND THERAPEUTIC USES

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

Method for preparing dual-functional hybrid thin-film for self-calibration detection of tumor-derived exosomes

Aptamer for ADAMTS5 and use for aptamer for ADAMTS5

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Nucleic acid-drug complex and use thereof

STEM-LOOP COMPOSITIONS AND METHODS FOR INHIBITING INTERLEUKIN-8

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Heterochiral nucleic acid strand-displacement systems and methods

Von Willebrand Factor (VWF)-targeting agents and methods of using the same

SUBSTITUTION OF THE MESSENGER RNA CAP WITH TWO RNA SEQUENCES INTRODUCED AT THE 5-PRIME END THEREOF

COMPOSITIONS FOR DELIVERY OF CARGO TO CELLS

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS

Aptamer of nattokinase and method for screening the aptamer

COMPOSITIONS FOR SELECTION OF APTAMERS

RNA targeting of mutations via suppressor tRNAs and deaminases

APTAMER FOR SCLEROSTIN AND USE THEREOF

PROTECTED ANTIBODY-DRUG AND APTAMER-DRUG CONJUGATES

Polymer microneedle mediated drug delivery

Closed loop continuous aptamer development system

NUCLEIC ACID APTAMERS

Oligonucleotides comprising modified nucleosides

Method of producing an aptamer and uses thereof

RNA TARGETING OF MUTATIONS VIA SUPPESSOR tRNAs AND DEAMINASES

ULTRASENSITIVE AND MULTIPLEXED CELL-FREE BIOSENSORS USING CASCADED AMPLIFICATION AND POSITIVE FEEDBACK

C5a binding nucleic acids

Aptamers for targeting coagulation factor XIII and uses thereof

REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT SCREENING METHOD, AND REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT

Aptamer Compositions and Methods of Use Thereof

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS

Compositions and methods to treat cancer

TREATMENT OF RAPIDLY EVOLVING BIOLOGICAL ENTITIES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS

METHOD FOR PRODUCING T CELLS MODIFIED BY CHIMERIC ANTIGEN RECEPTOR

Aptamers for targeted activation of T cell-mediated immunity

Artificially manipulated immune cell

APTAMER BASED METHODS FOR PROTEIN DETECTION

Engineered gyri-like mutein aptamers, and related methods

SDF-1 Binding Nucleic Acids

APTAMER BIOSENSORS USEFUL FOR DETECTING HORMONES, HORMONE MIMICS, AND METABOLITES THEREOF

Materials and methods for the delivery of therapeutic nucleic acids to tissues

Luminescent layered composition and a method for using the composition

VISUAL AND MODULAR DETECTION OF NUCLEIC ACIDS WITH ENZYME-ASSISTED NANOTECHNOLOGY

Aptamers specific for TLR-4 and uses thereof

Nucleic acid compounds for binding growth differentiation factor 11

Method for producing nucleic acid molecule, biomaterial, and method for producing biomaterial

TARGETING LIGANDS FOR TAU PATHOLOGY

Insulin-responsive glucagon delivery patch

FUNCTIONAL LIGANDS TO DICAMBA

Nucleic acid based biosensor and methods thereof

NUCLEIC ACID APTAMERS TARGETING LYMPHOCYTE ACTIVATION GENE 3 (LAG-3) AND USES THEREOF

Optimized variants of anti-VEGF antibodies

RNA nanoparticles for brain tumor treatment

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

SYSTEMS AND METHODS FOR ALLERGEN DETECTION

CRISPR EFFECTOR SYSTEM BASED MULTIPLEX DIAGNOSTICS

TISSUE SPECIFIC MARKERS FOR PREOPERATIVE AND INTRAOPERATIVE LOCALIZATION AND VISUALIZATION OF TISSUE

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Method for isolating cross-reactive aptamer and use thereof

Compositions and Methods for Treating, Ameliorating, and/or Preventing Viral Infections

SYNTHETIC NON-CODING RNAS

Compositions and methods for template-free geometric enzymatic nucleic acid synthesis

TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS

Methods and compositions for protein and peptide sequencing

BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER

In situ cell analysis in cell culture system

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

OLIGONUCLEOTIDE PROBES AND USES THEREOF

Oligonucleotide probes and uses thereof

FLUIDIC DEVICES WITH FREEZE-THAW VALVES WITH ICE-NUCLEATING AGENTS AND RELATED METHODS OF OPERATION AND ANALYSIS

Interferon production using short RNA duplexes

NUCLEIC ACID FOR EXPRESSING PROTEIN IN MITOCHONDRIA, LIPID MEMBRANE STRUCTURE ENCAPSULATING SAID NUCLEIC ACID, AND USE THEREOF

Method of treating inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) or gluten hypersensitivity by administering an elastase 2A (ELA2A) inhibitor

Material for capturing circulating cells in the blood, method of preparation and use

METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-BTNL2 AND IMMUNE CHECKPOINT BLOCKADE AGENTS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS

Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetes

ANTIGENIC PEPTIDES DERIVING FROM PCSK2 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

Aptamer method

Preparation and use of nanoparticle-doped RNA hydrogel targeting to triple negative breast cancer

Modified tracrRNAs gRNAs, and uses thereof

Nucleic acid aptamers to treat histone-induced disease states

Amphiphilic polynucleotides

METHOD FOR SELECTING HIGHLY EFFICIENT STEM CELL, USING PROTEIN MARKER GRP78

Method for preparing nanocomposite and label-free aptamer electrochemical sensor of gamma-interferon based on the nanocomposite

Anti-chymase aptamer and use for same

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Aptamer based affinity capture methods for the selective enrichment of human immunoglobulin Fc domains

DNA aptamer specifically binding to TB7.7, and use thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Target substance detection method, target substance detection kit, and target substance detection system

Detection of microbial endotoxins in oral samples using aptamers

Oligonucleotide-tethered nucleotides

Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Inhibition of nucleic acid polymerases by endonuclease v-cleavable oligonucleotide ligands

Homologous recombination via transcriptional activation

METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

Compositions and methods for inhibiting factor D

Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands

ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY CONTRAST AGENTS

DNA-CHIMERIC ANTIGEN RECEPTOR T CELLS FOR IMMUNOTHERAPY

Aptamers against

Aptamers against

Ligand binding assay for detecting gibberellins

CTLA-4 aptamer conjugates

Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

RNA nanostructures, methods of making, and uses thereof

APPLICATION OF APTAMER IN RECOGNITION AND BINDING OF ALKALINE PHOSPHATASE HETERODIMER OR TUMOR DETECTION

Molecular sensor selection

Aptamers binding to legionella pneumophila

Anti-cancer RNA aptamers

Magnetic particle conjugates and methods of activating cell signaling

Thrombus imaging aptamers and methods of using same

Screening artificial nucleic acids by particle display

DNA aptamer specifically binding to ESAT6, and use thereof

Aptamer conjugates with N-heterocyclic carbene metal complexes for targeted drug delivery

Peptides and combination thereof for use in the immunotherapy against cancers

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

APTAMER TEMPLATE AND METHOD FOR PREPARING APTAMER BY USING SAME

Aptamers for the treatment of sickle cell disease

Methods for screening nucleic acid aptamers

Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease

DNA aptamer specifically binding to CFP10, and use thereof

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Method of treating with a peptide

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

Hybrid enzymatic aptamer sensors

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Aptamer compositions and the use thereof

Oligonucleotide compositions and methods thereof

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

RNA HYDROGELS

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

Method of treating with a peptide

APTAMER AGAINST M.TB MPT51 AND USES THEREOF

Nucleolin-targeting aptamers and methods of using the same

RNA targeting of mutations via suppressor tRNAs and deaminases

Therapeutic oligonucleotides

SYNTHETIC HAMMERHEAD RIBOZYMES WITH LIGAND-RESPONSIVE TERTIARY INTERACTIONS

OLIGONUCLEOTIDE PROBES AND USES THEREOF

RNA-modulating agents

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Nucleic acid molecule with anti-inflammatory and anti-coagulant and organ-protective properties

RNA targeting of mutations via suppressor tRNAs and deaminases

Switchable CAS9 nucleases and uses thereof

NUCLEIC ACID APTAMER FOR INHIBITING ACTIVITY OF GENOME-EDITING ENZYME

COMPOSITIONS AND METHODS FOR REGULATION OF GENE EXPRESSION WITH, AND DETECTION OF, FOLINIC ACID AND FOLATES

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

Aptamers, biosensors and detection methods for common azole-class antifungal drugs

Wheat allergen-binding nucleic acid molecule and use thereof

Methods For Generating Epitopes For Binding To Recognition Molecules By Templated Assembly

High throughput cell-based screening for aptamers

Combination of AS1411 and SAPC-DOPS for the treatment of glioblastoma multiforme

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Nucleic acid oligomers and uses therefor

Peptides and combination thereof for use in the immunotherapy against cancers

Stem-loop compositions and methods for inhibiting factor D

Targeting synaptogyrin-3 in tauopathy treatment

RNA LIGAND-DISPLAYING EXOSOMES FOR SPECIFIC DELIVERY OF THERAPEUTICS TO CELL BY RNA NANOTECHNOLOGY

Aptamer biosensors useful for detecting hormones, hormone mimics, and metabolites thereof

USE OF BIOLOGICAL RNA SCAFFOLDS WITH IN VITRO SELECTION TO GENERATE ROBUST SMALL MOLECULE BINDING APTAMERS FOR GENETICALLY ENCODABLE BIOSENSORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Peptides and combination thereof for use in the immunotherapy against cancers